In a prospective, randomized study we performed left atrial (LA) functional imaging and late gadolinium enhancement (LGE) in patients undergoing pulmonary vein isolation with ablation of the anterior mitral line to evaluate LA function and visibility of the anterior mitral line and to explore the relationship of these factors to short- and long-term procedural success. Functional imaging of the LA and LGE-visualization 15 min post i.v. administration of gadobutrol was performed on a 3 T MRI system before and after ablation. Patients were grouped in (a) subjects with sinus rhythm, and (b) subjects without sinus rhythm at the follow-up-MRI. Eight patients were excluded due to poor image quality. 37 patients were allotted to group a, 4 patients to group b. Group a showed a significant improvement in ejection fraction (22.3 ± 7.1% vs. 27.2 ± 5.5%; p < 0.001), end-systolic volume (111.6 ± 48.3 ml vs. 96.9 ± 37.2 ml; p = 0.002), stroke volume (30.2 ± 12.6 ml vs. 35.6 ± 12.6 ml; p = 0.003) and LGE (12.5% vs. 83.7%; p < 0.001). Group b showed no significant changes in functional parameters or LGE. Patients with successful therapy at 12 months showed significantly lower volumes in the baseline MRI. Scarring along the ablation pathways could be visualized with LGE. Patients with successful CA showed a significant improvement in LA cardiac parameters. Pre-ablation atrial volume seems to be a predictor for long-term success.
Cardiac MRI Atrial function Catheter ablation Scarring Anterior mitral line Gadolinium late enhancement Atrial fibrillation
This is a preview of subscription content, log in to check access.
Compliance with ethical standards
Conflict of interest
Heidi Estner receives an investigator-initiated grant by Biosense Webster, holds honorary lectures for Boehringer Ingelheim Boston and is an advisory for Boston Scientific. The other authors declare that they have no potential conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
Chugh SS, Havmoeller R, Narayanan K et al (2014) Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 129(8):837–847CrossRefGoogle Scholar
Ferrari R, Bertini M, Blomstrom-Lundqvist C et al (2016) An update on atrial fibrillation in 2014: from pathophysiology to treatment. Int J Cardiol 203:22–29CrossRefGoogle Scholar
Kirchhof P, Lip GY, Van Gelder IC et al (2014). Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options–a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. Europace 14(1):8–27CrossRefGoogle Scholar
Fichtner S, Sparn K, Reents T et al (2015) Recurrence of paroxysmal atrial fibrillation after pulmonary vein isolation: is repeat pulmonary vein isolation enough? A prospective, randomized trial. Europace 17(9):1371–1375CrossRefGoogle Scholar
Sandstede JJ, Lipke C, Beer M et al (2000) Analysis of first-pass and delayed contrast-enhancement patterns of dysfunctional myocardium on MR imaging: use in the prediction of myocardial viability. AJR Am J Roentgenol 174(6):1737–1740CrossRefGoogle Scholar
Setser RM, Bexell DG, O’Donnell TP et al (2003) Quantitative assessment of myocardial scar in delayed enhancement magnetic resonance imaging. J Magn Reson Imaging 18(4):434–441CrossRefGoogle Scholar
Oakes RS, Badger TJ, Kholmovski EG et al (2009) Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 119(13):1758–1767CrossRefGoogle Scholar
McGann CJ, Kholmovski EG, Oakes RS et al (2008) New magnetic resonance imaging-based method for defining the extent of left atrial wall injury after the ablation of atrial fibrillation. J Am Coll Cardiol 52(15):1263–1271CrossRefGoogle Scholar
Higuchi K, Akkaya M, Akoum N, Marrouche NF (2014) Cardiac MRI assessment of atrial fibrosis in atrial fibrillation: implications for diagnosis and therapy. Heart (Br Card Soc) 100(7):590–596Google Scholar
Peters DC, Wylie JV, Hauser TH et al (2007) Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience. Radiology 243(3):690–695CrossRefGoogle Scholar
Hunter RJ, Jones DA, Boubertakh R et al (2013) Diagnostic accuracy of cardiac magnetic resonance imaging in the detection and characterization of left atrial catheter ablation lesions: a multicenter experience. J Cardiovasc Electrophysiol 24(4):396–403CrossRefGoogle Scholar
Beukema WP, Elvan A, Sie HT, Misier AR, Wellens HJ (2005) Successful radiofrequency ablation in patients with previous atrial fibrillation results in a significant decrease in left atrial size. Circulation 112(14):2089–2095CrossRefGoogle Scholar
Muller H, Noble S, Keller PF et al (2008) Biatrial anatomical reverse remodelling after radiofrequency catheter ablation for atrial fibrillation: evidence from real-time three-dimensional echocardiography. Europace 10(9):1073–1078CrossRefGoogle Scholar
Sallach SM, Peshock RM, Reimold S (2007) Noninvasive cardiac imaging in pulmonary hypertension. Cardiol Rev 15(2):97–101CrossRefGoogle Scholar
Jahnke C, Fischer J, Gerds-Li JH et al (2011) Serial monitoring of reverse left-atrial remodeling after pulmonary vein isolation in patients with atrial fibrillation: a magnetic resonance imaging study. Int J Cardiol 153(1):42–46CrossRefGoogle Scholar
Khan IA (2003) Atrial stunning: basics and clinical considerations. International J Cardiol 92(2–3):113–128CrossRefGoogle Scholar